Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE009154 |
ID: | TCMBANKHE009154 |
植物拉丁名: |
|
功能与主治: | To relieve rheumatic conditions, and to remove damp-heat./Wind-damp impediment pain, hypertonicity of sinews and vessels, aching pain in joints, late afternoon tidal fever, child gan accumulation with fever. |
药用植物名: | 秦艽 |
药用部位: | dried root |
药味: | Minor cold; Pungent; Bitter |
经络: | Stomach; Liver; Gallbladder |
临床特征: | 1. Inhibiting experimental arthritis in mice and decreasing capillary permeability.2. Anti-allergric.3. Inducing transient hypotensive effect. |
治疗类型: | 祛风湿清热药 |
TCM_ID_id: | 6353 |
SymMap_id: | 324 |
TCMSP_id: | 574 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000006 | evodiamine | l-Evodiamine; BDBM50366821; BB_NC-1930; ZINC00898159; Evodiamine, <i>Evodia rutaecarpa; evodiamine ; 518-17-2; CHEMBL486598; Evodiamine; ZINC2031813; C09187 | C19H17N3O | 303.36 | CN1C2C3=C(CCN2C(=O)C4=CC=CC=C41)C5=CC=CC=C5N3 |
| TCMBANKIN000064 | diosgenin | AKOS025402315; MolPort-028-744-580; (25R)-5-Spirosten-3beta-ol; 3beta-Hydroxy-5-spirostene; nitogenin; NSC 226132; Spirost-5-en-3-ol, (3beta,25S)-; diosgenin ; AC-8024; 512-04-9; 22-epi-Yamogenin; C08898; D1634_SIGMA | C27H42O3 | 414.62 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)O)C)C)C)OC1 |
| TCMBANKIN002088 | Gentiana glycosides | ||||
| TCMBANKIN002387 | Methoxy eel vine acid | ||||
| TCMBANKIN003665 | evoden | C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O | |||
| TCMBANKIN004217 | Gentiana amide | ||||
| TCMBANKIN004891 | Glycolipid large leaf glycosides C | ||||
| TCMBANKIN005115 | Sophora phenol | ||||
| TCMBANKIN007838 | swertiamarin_qt | Swertiamarine_qt | C16H22O10 | 374.34 | |
| TCMBANKIN007887 | Oak Apple acid | ||||
| TCMBANKIN009367 | Glycolipid large leaf glycosides D | ||||
| TCMBANKIN010187 | loganic acid_qt | C16H24O10 | 376.36 | ||
| TCMBANKIN010526 | macrophylloside d | Macrophylloside D | C25H34O14 | 558.5 g/mol | CC1(C=CC2=CC(=C(C=C2O1)OC)C(=O)OC3C(C(C(C(O3)COC4C(C(C(C(O4)CO)O)O)O)O)O)O)C |
| TCMBANKIN010613 | Haba glycosides | ||||
| TCMBANKIN010830 | Big leaf glycosides B | ||||
| TCMBANKIN011074 | Big leaf glycosides A | ||||
| TCMBANKIN012990 | hydroxyevodiamine | hydroxy evodiamine; Ambotz526-43-2; 13b-Hydroxy-14-methyl-8,13,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one; MolPort-020-005-715; hydroxyevodiamine | C19H17N3O2 | 319.36 | |
| TCMBANKIN013075 | kurchaline | AC1NSXEA; (17Z)-3-(dimethylamino)-17-ethylidene-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-2,16-diol | C23H37NO2 | 359.5 g/mol | CC=C1C(CC2C1(CCC3C2CC=C4C3(CC(C(C4)N(C)C)O)C)C)O |
| TCMBANKIN013801 | macrophylloside c | 1-O-[(7-Methoxy-2,2-dimethyl-2H-1-benzopyran-6-yl)carbonyl]-beta-D-glucopyranose | C19H24O9 | 396.4 g/mol | CC1(C=CC2=CC(=C(C=C2O1)OC)C(=O)OC3C(C(C(C(O3)CO)O)O)O)C |
| TCMBANKIN014425 | α- incense tree aldehyde | ||||
| TCMBANKIN014832 | rutamine | rutamine | |||
| TCMBANKIN015785 | evgin | ||||
| TCMBANKIN016694 | gentianine | AKOS005266580; Gentianine; ZINC1530467; MCULE-3837896278; 439-89-4; NSC606848; 4-(2-hydroxyethyl)-5-vinylnicotinic acid gamma-lactone; BB_NC-0759; 5-vinyl-3-hydro-4H-pyrano[3,4-c]pyridin-1-one; 1H-Pyrano(3,4-c)pyridin-1-one, 5-ethenyl-3,4-dihydro- (9CI); 4-27-00-02817 (Beilstein Handbook Reference); Gencianina; Bio-0278; Q-100479; C2PD310UXB; 1H-Pyrano[3,4-c]pyridin-1-one, 5-ethenyl-3,4-dihydro-; 5-ethenyl-3,4-dihydropyrano[3,4-c]pyridin-1-one; Erythricine; FCH842303; ZINC01530467; From Schultesia guianensis malme (Mata-Zombando); C06525; 5-ethenyl-3,4-dihydro-1H-pyrano[3,4-c]pyridin-1-one; UNII-C2PD310UXB; 5-Ethenyl-3,4-dihydro-1H-pyrano(3,4-c)pyridin-1-one; 5-vinyl-3,4-dihydropyrano[3,4-c]pyridin-1-one; ST023290; CHEBI:28981; NSC-606848; W1062; 1H-Pyrano[3,4-c]pyridin-1-one,5-ethenyl-3,4-dihydro-; 4-(2-Hydroxyethyl)-5-vinylnicotinic lactone; MolPort-002-507-225; SCHEMBL2216852; AC1L74P3 | C10H9NO2 | 175.18 g/mol | C=CC1=CN=CC2=C1CCOC2=O |
| TCMBANKIN016758 | Methyl lignite | CH4 | C | ||
| TCMBANKIN017701 | erythrocentauricacid | Erythrocentauric acid | C10H8O4 | 192.17 g/mol | C1COC(=O)C2=C1C(=CC=C2)C(=O)O |
| TCMBANKIN018974 | erocarpine | ||||
| TCMBANKIN019603 | Macrophylloside B_qt | C40H44O23 | 892.76 | ||
| TCMBANKIN019650 | isoevodiamine | Evodiamine, (+)-; 21-METHYL-3,13,21-TRIAZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(2)?]HENICOSA-2(10),4(9),5,7,15,17,19-HEPTAEN-14-ONE; SR-05000002159-2; MFCD06407824; E1012; 518-18-3; AS-15078; SR-05000002159; AC-24421; NCGC00163553-02; MolPort-003-983-878; ST51052658; AN-45498; N923; CCG-208627; d-Evodiamine; Evodiamine (Isoevodiamine); CHEMBL81925; SureCN682158; MCULE-3374039628; API0002668; 8,13,13b,14-Tetrahydro-14-methylindolo[2'3'-3,4]pyrido[2,1-b]quinazolin-5-[7H]-one; 21-methyl-3,13,21-triazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4,6,8,15(20),16,18-heptaen-14-one; CHEBI:95196; AKOS015894237; BRD-A68631409-001-01-3; (??)-Evodiamine; evodiamine, (S)-isomer; 21-methyl-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20] henicosa-2(10),4,6,8,15,17,19-heptaen-14-one; Oprea1_236793; BCP9000671; Isoevodiamine; Indol(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (S)-; BDBM50016250; LS-175304; PubChem18244; BC216230; Evodiamine;; SCHEMBL139349; NSC-258314; 5956-87-6; 14-METHYL-5-OXO-7,8-DIHYDRO-5H-INDOLO[2,3:3,4]PYRIDO[2,1-B]QUINAZOLIN-14-IUM-13-IDE; I05-0067; Indolo(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-; (+/-)-Evodiamine; Indol(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (13bS)-; s2382; AC1L461L; NSC258314; NCGC00163553-01; 8,13,13b,14-tetrahydro-14-methylindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7h)-one; AC1L9C8E; C19H17N3O | C19H17N3O | 303.4 g/mol | CN1C2C3=C(CCN2C(=O)C4=CC=CC=C41)C5=CC=CC=C5N3 |
| TCMBANKIN019670 | carboxy evodiamine | carboxyevodiamine | C20H17N3O3 | 347.4 g/mol | CN1C2C3=C(CC(N2C(=O)C4=CC=CC=C41)C(=O)O)C5=CC=CC=C5N3 |
| TCMBANKIN020274 | β- sitosterol-β-D- glucitol | ||||
| TCMBANKIN021103 | macrospegatrine | 18-Normacralstonidinium, 1,1',4-tridemethyl-4',21-dimethyl-17-methylene-, (4'alpha,15beta,16beta,21beta)-; Macrospegatrine; 113728-54-4 | C40H45N4O3+ | 629.8 g/mol | CC=C1C[N+]2(C3CC1C(C2CC4=C3NC5=C4C6=C(C=C5)OC7C(C6C)C8CC9C1=C(CC(C8C(=C)O7)N9)C2=CC=CC=C2N1)CO)C |
| TCMBANKIN021424 | Swertia bitter glycosides | ||||
| TCMBANKIN023580 | Gentianol | AC1NSVSL; gentianol; 1-methyl-6-oxo-1,3,4,5-tetrahydropyrano[3,4-c]pyridine-5-carbaldehyde | 193.22 | CC1C2=C(CCO1)C(C(=O)N=C2)C=O | |
| TCMBANKIN023811 | 7-O-methylmorroniside | 7-o-methyl morroniside; AC1O3DP6; methyl 3-methoxy-1-methyl-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,3,4,4a,8,8a-hexahydropyrano[3,4-c]pyran-5-carboxylate | C18H28O11 | 420.4 g/mol | CC1C2C(CC(O1)OC)C(=COC2OC3C(C(C(C(O3)CO)O)O)O)C(=O)OC |
| TCMBANKIN025358 | benzoic acid | Benzoic acid, 2-[(carboxymethyl)amino]-4-chloro-; 2-[(carboxymethyl)amino]-4-chlorobenzoic acid; DTXSID70455462; BG00311790; AC-17987; AX8062950; 2-carboxymethylamino-4-chlorobenzoic acid; KB-223858; AK140629; 99282-79-8; benzoicacid; CTK5I0315; 2-(Carboxymethyl-amino)-4-chloro-; AKOS015963713; SCHEMBL3236365; 2-(carboxymethylamino)-4-chlorobenzoic acid; benzoic acid ; 2-(CARBOXYMETHYL-AMINO)-4-CHLORO-BENZOIC ACID; AJ-79604; 2-((Carboxymethyl)amino)-4-chlorobenzoic acid; UDXGKLGUAJLLCJ-UHFFFAOYSA-N; ZINC21988796 | C7H6O2 | 122.12 | C1=CC(=C(C=C1Cl)NCC(=O)O)C(=O)O |
| TCMBANKIN027148 | smilagenin | EINECS 204-775-8; CHEBI:28933; (25R)-Spirostane-3beta-ol; C08913; 5beta-Spirostan-3beta-ol, (25R)- (8CI); (25R)-Spirostan-3.beta.-ol; Isosarsasapogenin; Spirostan-3-ol, (3.beta.,5.beta.,25R)-; Spirostan-3-ol, (3beta,5beta,25R)- (9CI); NSC93747; NSC 93747; (25R)-5beta-Spirostan-3beta-ol; SMP1_000275; SCHEMBL180193; AI3-44895; Isosarsapogenin; (25R)-Spirostan-3beta-ol; 126-18-1; Smilagenin; 5.beta.-Spirostan-3.beta.-ol, (25R)- | C27H44O3 | 416.6 g/mol | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)O)C)C)C)OC1 |
| TCMBANKIN030854 | neoketose | ||||
| TCMBANKIN031004 | wuchuyine | C10H13NO2 | 179.218 | ||
| TCMBANKIN031084 | Methyl montanate | octacosanoic acid methyl ester; Octacosanoic acid, methyl ester; METHYL OCTACOSANOATE; ZKHOYAKAFALNQD-UHFFFAOYSA-N; Methyl octacosanoate, analytical standard; methyl montanate; I14-19169; Octacosanoic acid,methyl ester; UNII-82S906Z1UB; Montanic acid, methyl ester; montanic acid methyl ester; 74701_FLUKA; AKOS015903301; Octacosanoic acid methyl ester (FAME MIX); C-48195; EINECS 259-754-6; 82S906Z1UB; TR-019630; Octacosanoic acid methyl ester; octacosanoicacidmethylester; ZINC85530556; CTK5A4000; SCHEMBL2349831; AC1L25X7; MFCD00042896; DTXSID60204204; 29684D9A-0749-4587-9B65-AA00AE9C4FC6; FT-0725009; 55682-92-3 | C29H58O2 | 438.77 | CCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)OC |
| TCMBANKIN032183 | Gentianidine | CHEMBL2007415; AIDS132749; AKOS006327911; 6-Methyl-3,4-dihydro-1H-pyrano[3,4-c]pyridin-1-one; NSC627383; 1H-Pyrano[3,4-c]pyridin-1-one,3,4-dihydro-6-methyl-; 6-methyl-3,4-dihydropyrano[4,3-d]pyridin-1-one; AIDS-132749; AC1Q6HRN; 2202/12/2; AC1L7LLL; 2202-12-2; ZINC1618969; FT-0730301; 6-methyl-3,4-dihydropyrano[3,4-c]pyridin-1-one; NCI60_008704; DTXSID90176485; SCHEMBL4075386; NSC-627383; 35G857GZ2P; gentianidine; 6-Methyl-3,4-dihydro-1H-pyrano(3,4-c)pyridin-1-one; UNII-35G857GZ2P; 1H-Pyrano(3,4-c)pyridin-1-one, 3,4-dihydro-6-methyl-; CTK4E8297 | C9H9NO2 | 163.17 g/mol | CC1=CC2=C(C=N1)C(=O)OCC2 |
| TCMBANKIN035244 | scabrans G5_qt | scabrans G4_qt; gentiopicrin_qt; gentiopicroside_qt; scabrans G3_qt | C16H20O9 | 356.32 | |
| TCMBANKIN036098 | Macrophylloside A_qt | C40H44O22 | 876.76 | ||
| TCMBANKIN036371 | Sweroside aglycone | (4aS,5R,6R)-6-hydroxy-5-vinyl-4,4a,5,6-tetrahydro-3H-pyrano[5,4-c]pyran-1-one; 6-alpha-Hydroxy-5-alpha-vinyl-4,4a-beta,5,6-tetrahydro-1H,3H-pyrano(3,4-c)pyran-1-one; 1H,3H-Pyrano(3,4-c)pyran-1-one, 5-ethenyl-4,4a,5,6-tetrahydro-6-hydroxy-, (4aalpha,5beta,6alpha)-; 15215-11-9; 1H,3H-Pyrano(3,4-c)pyran-1-one, 4,4a-beta,5,6-tetrahydro-6-alpha-hydroxy-5-alpha-vinyl-; 5-Ethenyl-4,4a,5,6-tetrahydro-6-hydroxy-1H,3H-pyrano(3,4-c)pyran-1-one (4aalpha,5beta,6alpha)-; (4aS,5R,6R)-5-ethenyl-6-hydroxy-4,4a,5,6-tetrahydro-3H-pyrano[5,4-c]pyran-1-one | C10H12O4 | 196.2 | C=CC1C2CCOC(=O)C2=COC1O |
| TCMBANKIN036641 | Nux Gly | ||||
| TCMBANKIN036668 | Swertia glycosides | ||||
| TCMBANKIN036904 | isovitexin | beta-D-isovitexin; LMPK12110338; Iso Vitexin; CHEBI:18330; 61383-34-4; C01714; 61838-34-4; 29702-25-8; 6-beta-D-Glucopyranosyl-4',5,7-trihydroxyflavone; 4H-1-Benzopyran-4-one, 6-beta-D-glucopyranosyl-5,7- dihydroxy-2-(4-hydroxyphenyl)-; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]-4-chromenone; 6-Glucosylapigenin; Isovitexin; Apigenin-6-C-glucoside; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]chromone; Apigenin 6-C-glucoside; 38953-85-4; NCGC00163578-01; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one; Saponaretin; 4H-1-Benzopyran-4-one, 6-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)- (VAN); AIDS339232; (1S)-1,5-anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-6-yl]-D-glucitol; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one; 6-C-Glucosylapigenin; AIDS-339232 | C20H18O10 | 418.351 | c1(C2=C([H])C(=O)c(c(O[H])c([C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])O3)c(O[H])c4[H])c4O2)c([H])c([H])c(O[H])c([H])c1[H] |
| TCMBANKIN037277 | Oleanolic acid | Olean-12-en-28-oic acid, 3.beta.-hydroxy-; s2334; Caryophyllin; AIDS014809; Giganteumgenin C; SMR000445561; oleanolicacid; (3-beta)-3-Hydroxyolean-12-en-28-oic acid; AIDS-014809; Olean-12-en-28-oic acid, 3-hydroxy-, (3-beta)-; EINECS 208-081-6; NSC 114945; OLEANOLIC ACID; Olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-; CCRIS 6493; AS-11663; SCHEMBL1699365; Virgaureagenin B; CHEBI:37659; MLS000697656; (4aS,5S,6aS,6bR,8R,8aR,10S,12aR,12bR,14bS)-10-Hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid; AKOS022168208; O5504_SIGMA; MolPort-016-633-333; Oleanolic Acid; Olean-12-en-28-oic acid, 3-beta-hydroxy- (8CI); Oleanic acid; 3beta-Hydroxyolean-12-en-28-oic acid; 3-beta-Hydroxyolean-12-en-28-oic acid; ST057162; Olean-12-en-28-oic acid, 3beta-hydroxy- (8CI); NSC114945; Oleanolic Acid (Caryophyllin); Astrantiagenin C; Olean-12-en-28-oic acid, 3-hydroxy-, (3.beta.)-; 508-02-1; (4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1H-picene-4-carboxylic acid; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; oleanolic acid | C30H48O3 | 457 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C(=O)O[H])C([H])([H])C3([H])[H])[C@@]34C( [H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
| TCMBANKIN037651 | Dehydroevodiamine | Dehydroevodiamine HCl; Dehydroevidiamine; AC1L4G2I; LS-190115; AK-693/21141027; BDBM50131047; AJ-63808; 14-Methyl-5-oxo-5,7,8,13-tetrahydro-indolo[2'',3'':3,4]pyrido[2,1-b]quinazolin-14-ium; ZINC13434330; CHEMBL81923 | 301.3 g/mol | ||
| TCMBANKIN038080 | Gentianal | 193.2 | |||
| TCMBANKIN038707 | alpha-amyrin | α-Amyrin; C08615; Urs-12-en-3-ol; Urs-12-en-3-ol, (3beta)- (9CI); alpha-Amyrine; Urs-12-en-3.beta.-ol; ST5411384; (3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol; (3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-Octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-eicosahydro-picen-3-ol; (3.beta.)-Urs-12-en-3-ol; 3-epi-α-amyrin; A834570; Urs-12-en-3-ol #; FSLPMRQHCOLESF-UHFFFAOYSA-N; EINECS 211-352-1; MCULE-7089035597; 12-ursen-3beta-ol; .alpha.-Amyrine; α-amyrin; NSC-114787; alpha-Amyrin; AC1L5E7U; Urs-12-en-3beta-ol; alpha-Amyrenol; Viminalol; 638-95-9; AIDS-070313; Epi-alpha-amyrin; 53017_FLUKA; AIDS070313; AC1Q7B25; .alpha.-Amyrin; 4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol; NSC 114787; NSC114787; alpha-amyrin ; Urs-12-en-3-ol, (3.beta.)-; .alpha.-Amyrenol; LMPR01060011; α- amyrin; SMP2_000308 | C30H50O | 426.72 | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C |
| TCMBANKIN038849 | Erythrocentaurin | Erythrocentaurine; AKOS032949101; 5-Formyl-3,4-dihydroisocoumarin; AC1L4RWZ; 3,4-Dihydro-1-oxo-1H-2-benzopyran-5-carbaldehyde; 1-Oxo-3,4-dihydro-1H-isochromene-5-carbaldehyde #; CTK4J2377; 295RS6D94V; 1-oxo-3,4-dihydroisochromene-5-carbaldehyde; CHEMBL3397161; DTXSID30198282; UNII-295RS6D94V; 1H-2-Benzopyran-5-carboxaldehyde, 3,4-dihydro-1-oxo-; 1-oxoisochroman-5-carbaldehyde; erythrocentaurin; 50276-98-7; AC1Q6Q8L; SCHEMBL1649253; 1-oxo-5-isochromancarboxaldehyde; TUADBWMDDLWUME-UHFFFAOYSA-N; ZINC3652723; 1-ketoisochroman-5-carbaldehyde | C10H8O3 | 176.17 | C1COC(=O)C2=CC=CC(=C21)C=O |
| TCMBANKIN039764 | Macrophylloside B | macrophylloside b | C41H46O22 | 891 | C1([H])([H])OC(=O)C(=C([H])O[C@@]([H])(O[C@@]2([H])[C@]([H])(OC(c3c([H])c([H])c([H])c(O[H])c3O[H])=O)[C@@]([H])(OC(C([H])([H])[H])=O)[C@]([H])(C([H])([H])C(=O)c4c([H])c([H])c([H])c(O[C@@]5([H])O[C@]([ H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]5([H])O[H])c4O[H])[C@@]([H])(C([H])([H])OC(C([H])([H])[H])=O)O2)[C@]6([H])C([H])=C([H])[H])[C@@]6(O[H])C1([H])[H] |
| TCMBANKIN043937 | qinjiaoamide | ||||
| TCMBANKIN043958 | Trilobatin | 436.4 g/mol | |||
| TCMBANKIN045208 | gentiatibetine | 26005-36-7; 8-methyl-1H,3H,4H-pyrano[3,4-c]pyridin-1-ol; Gentiatibetine; Alkaloid GT-A; 8-methyl-3,4-dihydro-1H-pyrano[3,4-c]pyridin-1-ol; AC1NSVSO; Gentiotibetine | C9H11NO2 | 165.19 | CC1=NC=CC2=C1C(OCC2)O |
| TCMBANKIN045577 | kurarinone | Kurarinone, >=98% (HPLC); CHEBI:66150; MolPort-039-339-013; SCHEMBL563362; C17446; (2S)-2-(2,4-dihydroxyphenyl)-7-hydroxy-5-methoxy-8-[(2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-3,4-dihydro-2H-1-benzopyran-4-one; J3.604.214A; (2S)-(-)-kurarinone; LMPK12140499; kurarinone ; Kurarinone; 7,2',4'-Trihydroxy-8-lavandulyl-5-methoxyflavanone; ZINC14711629; AKOS030530879; (2S)-2-(2,4-dihydroxyphenyl)-7-hydroxy-5-methoxy-8-[(2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-2,3-dihydro-4H-chromen-4-one; AK555456; (S)-2-(2,4-Dihydroxyphenyl)-7-hydroxy-5-methoxy-8-((R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl)chroman-4-one | C25H28O6 | 424.486 | c1(O[H])c(C([H])([H])[C@]([H])(C(=C([H])[H])C([H])([H])[H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])c(O[H])c(C(=O)\C([H])=C([H])\c2c([H])c([H])c(O[H])c([H])c2O[H])c(OC([H])([H])[H])c1[H] |
| TCMBANKIN046408 | isoorientin | isoorientin 7-olate; isoorientin(1-); Isoorientin; AIDS-026707; 2-(3,4-Dihydroxyphenyl)-6-beta-D-glucopyranosyl-5,7-dihydroxy-4H-1-benzopyran-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-6-beta-D-glucopyranosyl-5,7-dihydroxy-; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]-4-chromenone; C01821; NCGC00163566-01; (1S)-1,5-anhydro-1-[2-(3,4-dihydroxyphenyl)-5-hydroxy-7-oxido-4-oxo-4H-chromen-6-yl]-D-glucitol; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one; 4261-42-1; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]chromone; AIDS026707; CHEBI:58333; CHEBI:17965; (1S)-1,5-anhydro-1-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-6-yl]-D-glucitol; 6C-hexosyl luteolin; Homoorientin; isoorientin anion; isoorientin ; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one; Luteolin 6-C-glucoside | C21H20O11 | 448.377 | c12c(OC(c3c([H])c([H])c(O[H])c(O[H])c3[H])=C([H])C1=O)c([H])c(O[H])c([C@@]4([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O4)c2O[H] |
| TCMBANKIN046432 | Gentiopicroside tetraacetate | (5R-trans)-5,6-Dihydro-6-((2,3,4,6-tetra-O-acetyl-beta-D-glucopyranosyl)oxy)-5-vinyl-1H,3H-pyrano(3,4-c)pyran-1-one; EINECS 234-250-9; [(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4-ethenyl-8-oxo-4,6-dihydro-3H-pyrano[3,4-c]pyran-3-yl)oxy]oxan-2-yl]methyl acetate; AC1L3FBL; 11019-08-2; gentiopicroside tetraacetate | C24H28O13 | 524.5 g/mol | C1([H])([H])OC(=O)C(=C([H])O[C@@]([H])(O[C@@]2([H])[C@]([H])(OC(=O)C([H])([H])[H])[C@@]([H])(OC(=O)C([H])([H])[H])[C@]([H])(OC(=O)C([H])([H])[H])[C@@]([H])(C([H])([H])OC(=O)C([H])([H])[H])O2)[C@]3(C([ H])=C([H])[H])[H])C3=C1[H] |
| TCMBANKIN046690 | Roburic acid | roburicacid; roburic acid | C30H48O2 | 440.7 | CC1CCC2(CCC3(C(=CCC4C3(CCC(C4(C)CCC(=O)O)C(=C)C)C)C2C1C)C)C |
| TCMBANKIN046749 | rutaevin | Rutaevin; rutaevin ; C08779; 33237-37-5 | C26H30O9 | 487 | O1[C@@]([H])(C([H])([H])C(=O)OC2([H])[H])[C@]2([C@@]([H])(C([H])([H])C([H])([H])[C@]3(C([H])([H])[H])[C@@]45[C@]([H])(O4)C(=O)O[C@@]3([H])c6c([H])c([H])oc6[H])[C@@]5(C([H])([H])[H])[C@]([H])(O[H])C7=O )[C@@]7([H])C1(C([H])([H])[H])C([H])([H])[H] |
| TCMBANKIN046798 | 7-Methoxy-aristolochiac acid A | 3,4-Methylenedioxy-7,8-dimethoxy-10-nitrophenanthrene-1-carboxylic acid; AC1NSY17; 7-methoxyaristolochic acid a; 79185-74-3; 8,9-dimethoxy-6-nitronaphtho[2,1-g][1,3]benzodioxole-5-carboxylic acid | C18H13NO8 | 371.298 | c1(OC([H])([H])[H])c(OC([H])([H])[H])c(c([H])c(N(=O)=O)c(c(C(O[H])=O)c([H])c(OC([H])([H])O2)c23)c34)c4c([H])c1[H] |
| TCMBANKIN048641 | Macrophylloside A | macrophylloside a | C41H46O21 | 875 | C1([H])([H])OC(=O)C(=C([H])O[C@@]([H])(O[C@@]2([H])[C@]([H])(OC(c3c([H])c([H])c([H])c(O[H])c3O[H])=O)[C@@]([H])(OC(C([H])([H])[H])=O)[C@]([H])(C([H])([H])C(=O)c4c([H])c([H])c([H])c(O[C@@]5([H])O[C@]([ H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]5([H])O[H])c4O[H])[C@@]([H])(C([H])([H])OC(C([H])([H])[H])=O)O2)[C@]6([H])C([H])=C([H])[H])[C@@]6([H])C1([H])[H] |
| TCMBANKIN050239 | 6'-O-β-D-Glucopyranosylmorroniside | ||||
| TCMBANKIN057924 | l-aspargine | L-Asn; L-asparatamine; (2S)-2-azaniumyl-3-carbamoylpropanoate; CJ-24207; (2S)-4-amino-2-azaniumyl-4-oxobutanoate; CHEBI:58048; L-beta-asparagine; (2S)-2-azaniumyl-4-azanyl-4-oxidanylidene-butanoate; L-asparagine zwitterion; A820795; (2S)-2-ammonio-3-carbamoylpropanoate; A836895; asparagine; (2S)-4-amino-2-ammonio-4-oxobutanoate;asparagine;L-Asn; L-asparatamine; (2S)-2-azaniumyl-3-carbamoylpropanoate; CJ-24207; (2S)-4-amino-2-azaniumyl-4-oxobutanoate; CHEBI:58048; L-beta-asparagine; (2S)-2-azaniumyl-4-azanyl-4-oxidanylidene-butanoate; L-asparagine zwitterion; A820795; (2S)-2-ammonio-3-carbamoylpropanoate; A836895; (2S)-4-amino-2-ammonio-4-oxobutanoate | C4H8N2O3 | 132.12 g/mol | C(C(C(=O)[O-])[NH3+])C(=O)N |
| TCMBANKIN057926 | asparamide | 69833-18-7; BG01499101; L-Asparagine Monohydrate; ACMC-1B5BG; TRA0047172; AN-37801; CTK5D1417; 3130-87-8; DL-Asparagine monohydrate, >=99.0% (NT); DL-Asparaginemonohydrate; AM20090442; VC30810; AK-44638; C4H8N2O3.H2O; FT-0625440; D-(-)-Asparagine monohydrate; RBMGJIZCEWRQES-UHFFFAOYSA-N; DL-Asparagine monohydrate; D-alpha-Aminosuccinamic Acid; EN300-71864; ACMC-209fc6; FT-0609962; A814724; Dl-Asparagine Hydrate; D,L-Asn.H2O; ACMC-209m1g; AC-24125; ST50824199; asparagin hydrate; (+/-)-2-Aminosuccinic acid 4-amide, DL-Aspartic acid 4-amide; RTR-013321; 2,4-diamino-4-oxobutanoic acid hydrate; ASPARAGINE HYDRATE; AN-947; AC1LAWTA; AS-12270; 2,4-bis(azanyl)-4-oxidanylidene-butanoic acid hydrate; 2-amino-3-carbamoylpropanoic acid, hydrate; H-DL-Asn-OH; SBB058664; KS-00000KIH; ANW-27079; MFCD00151039; MolPort-001-766-703; KB-164589; Asparagine, d-l-, monohydrate; Asparagine, monohydrate(9CI); 2-amino-3-carbamoylpropanoic acid hydrate; 2,4-diamino-4-oxobutanoic acid;hydrate; AK319289; KB-50279; ST2419262; SCHEMBL50254; I04-0293; AC1Q59B4; 2,4-diamino-4-oxo-butanoic acid hydrate; TRA0016947; AKOS016001349 | C4H8N2O3 | 132.12 g/mol | C(C(C(=O)O)N)C(=O)N |
| TCMBANKIN058028 | swertiamarine | (4aR,5R,6S)-4a-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-5-vinyl-3,4,5,6-tetrahydropyrano[5,4-c]pyran-1-one; swertiamarin; AKOS016034281; (4aR,5R,6S)-5-ethenyl-4a-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4,5,6-tetrahydropyrano[5,4-c]pyran-1-one; (4aR,5R,6S)-4a-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-5-vinyl-3,4,5,6-tetrahydropyrano[5,4-c]pyran-1-one; ACon1_000546; (4aR,5R,6S)-4a-hydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-5-vinyl-3,4,5,6-tetrahydropyrano[5,4-c]pyran-1-one; 17388-39-5; C09800; MEGxp0_000871; iridiod monoterpenoid;Swertiamarin | C16H22O10 | 374.34 g/mol | C=CC1C(OC=C2C1(CCOC2=O)O)OC3C(C(C(C(O3)CO)O)O)O |
| TCMBANKIN058032 | gertiopicrin | gentiopicroside; 4-ethenyl-3-methyl-4,6-dihydro-3H-pyrano[3,4-c]pyran-8-one; 6-(hydroxymethyl)oxane-2,3,4,5-tetrol; A814958; MEGxp0_000872; (5R,6S)-5-ethenyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5,6-dihydro-3H-pyrano[5,4-c]pyran-1-one; Gentiopicroside; (5R,6S)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-5-vinyl-5,6-dihydro-3H-pyrano[5,4-c]pyran-1-one; EINECS 244-070-2; NSC-606402; LMPR01020110; C09782; ZINC04098340; 20831-76-9; (5R,6S)-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-5-vinyl-5,6-dihydro-3H-pyrano[5,4-c]pyran-1-one; NSC606402; gentiopicrin; ACon1_001284; (5R,6S)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-5-vinyl-5,6-dihydro-3H-pyrano[5,4-c]pyran-1-one; 1H,3H-Pyrano(3,4-c)pyran-1-one, 5-ethenyl-6-(beta-D-glucopyranosyloxy)-5,6-dihydro-, (5R-trans)-; (5R-trans)-6-(beta-D-Glucopyranosyloxy)-5,6-dihydro-5-vinyl-1H,3H-pyrano(3,4-c)pyran-1-one | C16H20O9 | 356.32 | C=CC1C(OC=C2C1=CCOC2=O)OC3C(C(C(C(O3)CO)O)O)O |
| TCMBANKIN058035 | 1H,3H-Pyrano(3,4-c)pyran-1-one, 5-ethenyl-6-(beta-D-glucopyranosyloxy)-4,4a,5,6-tetrahydro-, (4aS-(4aalpha,5beta,6alpha))-;sweroside | (4aS,5R,6S)-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-5-vinyl-4,4a,5,6-tetrahydro-3H-pyrano[5,4-c]pyran-1-one; ACon1_000233; (4aS,5R,6S)-5-ethenyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,4a,5,6-tetrahydro-3H-pyrano[5,4-c]pyran-1-one; 14215-86-2; (4aS,5R,6S)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-5-vinyl-4,4a,5,6-tetrahydro-3H-pyrano[5,4-c]pyran-1-one; ACon0_001457; (4aS,5R,6S)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-5-vinyl-4,4a,5,6-tetrahydro-3H-pyrano[5,4-c]pyran-1-one; MEGxp0_000813 | C16H22O9 | 358.34 | C=CC1C2CCOC(=O)C2=COC1OC3C(C(C(C(O3)CO)O)O)O |
| TCMBANKIN058291 | WLN: ZVR | HSDB 6360; Phenylcarboxamide; Benzenecarboxamide; 4-09-00-00725 (Beilstein Handbook Reference); 399337_ALDRICH; BENZOIC ACID,AMIDE; Amid kyseliny benzoove; 135828_ALDRICH; AIDS-018394; InChI=1/C7H7NO/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H2,8,9; STK069333; MLS000069472; Benzoic acid amide; ZINC00152996; ARONIS003511; AI3-01031; 27208-38-4; Amid kyseliny benzoove [Czech]; AIDS018394; NCGC00091355-01; Phenyl Carboxyamide; Phenylcarboxyamide; C09815; Benzamide; NSC3114; 55-21-0; CHEBI:28179; NSC 3114; NCGC00015142-01; Lopac-B-2009; BRN 0385876; Lopac0_000160; EINECS 200-227-7; EU-0100160; Benzoylamide; 150762_ALDRICH; CCRIS 4594; c0368; SMR000059089;benzamide | C7H7NO | 121.14 | C1=CC=C(C=C1)C(=O)N |
| TCMBANKIN058629 | rutacarpine | rutaecarpine;rutecarpine | C18H13N3O | 287.3 g/mol | C1CN2C(=NC3=CC=CC=C3C2=O)C4=C1C5=CC=CC=C5N4 |
| TCMBANKIN058630 | 14-formyldihydro rutaecarpine | 14-formyldihydrorutaecarpine | C19H15N3O2 | 317.3 g/mol | C1CN2C(C3=C1C4=CC=CC=C4N3)N(C5=CC=CC=C5C2=O)C=O |
| TCMBANKIN058638 | higenamine | UNII-6016M93W29; CHEBI:27751; (R)-Norcoclaurine; 6,7-Dihydroxy-(1R)-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline; 6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)-, (1R)-; (1R)-1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol; 6016M93W29; SCHEMBL5898913; AX8328517; DTXSID90331552; (+)-HIGENAMINE; UNII-TBV5O16GAP component WZRCQWQRFZITDX-CQSZACIVSA-N; CHEMBL501778; 6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)-, (R)-; C06347; (R)-(+)-Higenamine; (+)-Demethylcoclaurine; 106032-53-5; BDBM50242856; AC1L9ACA; (1R)-1-(4-hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol; AK00743742; (R)-1-(4-Hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol; Higenamine, (+)-; ZINC896041; demethylcoclaurine; demetahyl coclaurine | C16H17NO3 | 271.31 g/mol | C1CNC(C2=CC(=C(C=C21)O)O)CC3=CC=C(C=C3)O |
| TCMBANKIN058761 | (E)ocimene | (E)- ocimene; (E)-ocimene;p-Ocimene;3,7-Dimethyl-1,3,6-octatriene;trans-ocimene;trans- beta- Ocimene;ocimene;β-trans-ocimene;3,7-dimethyl-1,3e,6-octatriene;3,7-Dimethylocta-1,3,6-triene; 3,7-Dimethyl-1,3,6-octatriene (natural); beta-trans-Ocimene; EINECS 223-241-5; 74730_FLUKA; 11009-78-2; ST5410145; 3,7-Dimethyl-1,3,6-octatrien; 27400-72-2; FEMA No. 3539; 3,7-DIMETHYL-1,3,6-OCTATRIENE; (E)-3,7-Dimethyloctatriene; 1856-63-9; 11022-64-3; EINECS 237-641-2; BETA-OCIMENE, TRANS; 1,3,6-Octatriene, 3,7-dimethyl-, (E)-; .beta.-trans-Ocimene; 13877-91-3; .beta.-Ocimene; Octatriene, 3,7-dimethyl-, (E)-; beta-Ocimene; trans-beta-Ocimene; 1,3,6-Octatriene, 3,7-dimethyl-; Ocimene, beta-; 3779-61-1; (E)-3,7-Dimethylocta-1,3,6-triene; Ocimene trans-beta-form; (3E)-3,7-dimethylocta-1,3,6-triene; C09873;trans-β-Oci-mene; Trans- β- ocimene; trans-beta-ocimene;EINECS 249-805-0; AC1O5HAL; LS-98065; (3E,5E)-3,7-dimethylocta-1,3,5-triene; 2,6-Dimethyloctane, hexadehydro derivative; 29714-87-2; Dimethyloctatriene (mixed isomer);beta-trans-ocimene;3,7-Dimethylocta-1,3,6-triene; 3,7-Dimethyl-1,3,6-octatriene (natural); beta-trans-Ocimene; EINECS 223-241-5; 74730_FLUKA; 11009-78-2; ST5410145; 3,7-Dimethyl-1,3,6-octatrien; 27400-72-2; FEMA No. 3539; 3,7-DIMETHYL-1,3,6-OCTATRIENE; (E)-3,7-Dimethyloctatriene; 1856-63-9; 11022-64-3; EINECS 237-641-2; BETA-OCIMENE, TRANS; 1,3,6-Octatriene, 3,7-dimethyl-, (E)-; .beta.-trans-Ocimene; 13877-91-3; .beta.-Ocimene; Octatriene, 3,7-dimethyl-, (E)-; beta-Ocimene; trans-beta-Ocimene; 1,3,6-Octatriene, 3,7-dimethyl-; Ocimene, beta-; 3779-61-1; (E)-3,7-Dimethylocta-1,3,6-triene; Ocimene trans-beta-form; (3E)-3,7-dimethylocta-1,3,6-triene; C09873;ci-mene; Trans- β- ocimene; trans-beta-ocimene;EINECS 249-805-0; AC1O5HAL; LS-98065; (3E,5E)-3,7-dimethylocta-1,3,5-triene; 2,6-Dimethyloctane, hexadehydro derivative; 29714-87-2; Dimethyloctatriene (mixed isomer);beta-trans-ocimene | C10H16 | 136.23 g/mol | CC(=CCC=C(C)C=C)C |
| TCMBANKIN058861 | ginsenoside rd;20-glucosylginsenosiderf;20-glucosylginsenosiderf | ginsenoside-rd; ginsenosiderd; A829210; 2-(hydroxymethyl)-6-[6-(hydroxymethyl)-2-[[17-[2-[6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-3,12-bis(oxidanyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-b; 2-[[2-[[3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[6-methyl-2-[[3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]hept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)-3-oxanyl]oxy]-6;(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(6S,14R)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; 20-glucosylginsenoside rf; AC1O3DDF;;20-glucosylginsenosiderf;20-glucosylginsenosiderf | C48H82O18 | 947.15 | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)CO)O)O)O)C |
| TCMBANKIN058928 | 1-(5,7,8-trimethoxy-2,2-dimethylchromen-6-yl)ethanone | 1-(5,7,8-trimethoxy-2,2-dimethyl-chromen-6-yl)ethanone; 1-(5,7,8-trimethoxy-2,2-dimethyl-6-chromenyl)ethanone; Ethanone, 1-(5,7,8-trimethoxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-; Ketone, methyl 5,7,8-trimethoxy-2,2-dimethyl-2H-1-benzopyran-6-yl | C16H20O5;C26H30O9 | 292.33 g/mol | CC(=O)C1=C(C2=C(C(=C1OC)OC)OC(C=C2)(C)C)OC |
| TCMBANKIN059495 | 2-methoxyanofinic acid | C13H14O4 | 234.25 g/mol | CC1(C=CC2=CC(=C(C=C2O1)OC)C(=O)O)C | |
| TCMBANKIN059496 | evodol | C26H28O9 | 484.5 | CC1(C2=C(C(=O)C3(C(C24COC(=O)CC4O1)CCC5(C36C(O6)C(=O)OC5C7=COC=C7)C)C)O)C | |
| TCMBANKIN059505 | evodin | C26H30O8 | 470.5 g/mol | CC1(C2CC(=O)C3(C(C24COC(=O)CC4O1)CCC5(C36C(O6)C(=O)OC5C7=COC=C7)C)C)C | |
| TCMBANKIN060308 | Venoterpine | C9H11NO | 149.19g/mol | CC1C(CC2=C1C=NC=C2)O | |
| TCMBANKIN060512 | smilagenin | C27H44O3 | 416.6 g/mol | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)O)C)C)C)OC1 | |
| TCMBANKIN060544 | alpha-amyrin | C30H50O | 426.72 g/mol | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C | |
| TCMBANKIN060693 | Sitogluside | C35H60O6 | 576.85g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN060876 | 5,8-tetradecadienoic acid | C14H24O2 | 224.34g/mol | CCCCCC=CCC=CCCCC(=O)O | |
| TCMBANKIN061138 | Montanic acid | C28H56O2 | 424.7 g/mol | CCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061298 | GoshuyuamideII | C19H17N3O2 | 319.39 | CN1C2=CC=CC=C2C(=O)N(C1=O)CCC3=CNC4=CC=CC=C43 | |
| TCMBANKIN061384 | synephrine | M-2845;oxedrine | C9H13NO2 | 167.2 g/mol | CNCC(C1=CC=C(C=C1)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab